Filed: 5/15/2023ACC: 0001214659-23-007097
📋 What this filing means
TCG CROSSOVER MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 22 equity positions with a total reported market value of $513.03M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
22
Positions
$513.03M
Total AUM (reported)
50.38M
Total Shares
Allocation by class
COMM$491.65M95.8%
ADS$13.05M2.5%
SPONSORED ADS$8.33M1.6%
Portfolio Concentration
Top 3$202.81M39.5%
4–10$197.19M38.4%
11–25$113.03M22.0%
Top 3 weight
39.5%
Top 10 weight
78.0%
Voting Authority Distribution
Total shares with voting rights: 50.38M
Sole
Full voting authority
50.38M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole22
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings22
Rows:
IVERIC BIO INC
SOLEShares5.14M
TypeSH
Market value$125.08M
24.38%
Sole
5.14M
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC
SOLEShares3.63M
TypeSH
Market value$39.18M
7.64%
Sole
3.63M
Shared
0.00
None
0.00
GERON CORP
SOLEShares17.77M
TypeSH
Market value$38.55M
7.51%
Sole
17.77M
Shared
0.00
None
0.00
MADRIGAL PHARMACEUTICALS INC
SOLEShares149.92K
TypeSH
Market value$36.32M
7.08%
Sole
149.92K
Shared
0.00
None
0.00
TYRA BIOSCIENCES INC
SOLEShares1.99M
TypeSH
Market value$31.96M
6.23%
Sole
1.99M
Shared
0.00
None
0.00
VENTYX BIOSCIENCES, INC
SOLEShares815.72K
TypeSH
Market value$27.33M
5.33%
Sole
815.72K
Shared
0.00
None
0.00
KALVISTA PHARMACEUTICALS, INC
SOLEShares3.40M
TypeSH
Market value$26.69M
5.20%
Sole
3.40M
Shared
0.00
None
0.00
CYMABAY THERAPEUTICS INC
SOLEShares3.05M
TypeSH
Market value$26.58M
5.18%
Sole
3.05M
Shared
0.00
None
0.00
VECTIVBIO HOLDING AG
SOLEShares3.11M
TypeSH
Market value$26.50M
5.16%
Sole
3.11M
Shared
0.00
None
0.00
AEROVATE THERAPEUTICS INC
SOLEShares1.08M
TypeSH
Market value$21.81M
4.25%
Sole
1.08M
Shared
0.00
None
0.00
DYNE THERAPEUTICS, INC
SOLEShares1.65M
TypeSH
Market value$19.01M
3.71%
Sole
1.65M
Shared
0.00
None
0.00
KURA ONCOLOGY INC
SOLEShares1.42M
TypeSH
Market value$17.41M
3.39%
Sole
1.42M
Shared
0.00
None
0.00
VIRIDIAN THERAPEUTICS, INC
SOLEShares663.61K
TypeSH
Market value$16.88M
3.29%
Sole
663.61K
Shared
0.00
None
0.00
SILENCE THERAPEUTICS PLC
SOLEShares2.10M
TypeSH
Market value$13.05M
2.54%
Sole
2.10M
Shared
0.00
None
0.00
IMMUNOVANT, INC
SOLEShares654.85K
TypeSH
Market value$10.16M
1.98%
Sole
654.85K
Shared
0.00
None
0.00
ENTRADA THERAPEUTICS INC
SOLEShares584.96K
TypeSH
Market value$8.48M
1.65%
Sole
584.96K
Shared
0.00
None
0.00
STRUCTURE THERAPEUTICS INC
SOLEShares350K
TypeSH
Market value$8.33M
1.62%
Sole
350K
Shared
0.00
None
0.00
MERUS BV
SOLEShares300K
TypeSH
Market value$5.52M
1.08%
Sole
300K
Shared
0.00
None
0.00
ACLARIS THERAPEUTICS INC
SOLEShares529.84K
TypeSH
Market value$4.29M
0.84%
Sole
529.84K
Shared
0.00
None
0.00
CABALETTA BIO, INC
SOLEShares486.80K
TypeSH
Market value$4.03M
0.78%
Sole
486.80K
Shared
0.00
None
0.00
C4 THERAPEUTICS, INC.
SOLEShares1.25M
TypeSH
Market value$3.92M
0.77%
Sole
1.25M
Shared
0.00
None
0.00
ALPINE IMMUNE SCIENCES INC
SOLEShares253.07K
TypeSH
Market value$1.95M
0.38%
Sole
253.07K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
IVERIC BIO INCSOLE | COMM | 5.14M | SH | $125.08M 24.38% | 5.14M | 0.00 | 0.00 |
COGENT BIOSCIENCES INCSOLE | COMM | 3.63M | SH | $39.18M 7.64% | 3.63M | 0.00 | 0.00 |
GERON CORPSOLE | COMM | 17.77M | SH | $38.55M 7.51% | 17.77M | 0.00 | 0.00 |
MADRIGAL PHARMACEUTICALS INCSOLE | COMM | 149.92K | SH | $36.32M 7.08% | 149.92K | 0.00 | 0.00 |
TYRA BIOSCIENCES INCSOLE | COMM | 1.99M | SH | $31.96M 6.23% | 1.99M | 0.00 | 0.00 |
VENTYX BIOSCIENCES, INCSOLE | COMM | 815.72K | SH | $27.33M 5.33% | 815.72K | 0.00 | 0.00 |
KALVISTA PHARMACEUTICALS, INCSOLE | COMM | 3.40M | SH | $26.69M 5.20% | 3.40M | 0.00 | 0.00 |
CYMABAY THERAPEUTICS INCSOLE | COMM | 3.05M | SH | $26.58M 5.18% | 3.05M | 0.00 | 0.00 |
VECTIVBIO HOLDING AGSOLE | COMM | 3.11M | SH | $26.50M 5.16% | 3.11M | 0.00 | 0.00 |
AEROVATE THERAPEUTICS INCSOLE | COMM | 1.08M | SH | $21.81M 4.25% | 1.08M | 0.00 | 0.00 |
DYNE THERAPEUTICS, INCSOLE | COMM | 1.65M | SH | $19.01M 3.71% | 1.65M | 0.00 | 0.00 |
KURA ONCOLOGY INCSOLE | COMM | 1.42M | SH | $17.41M 3.39% | 1.42M | 0.00 | 0.00 |
VIRIDIAN THERAPEUTICS, INCSOLE | COMM | 663.61K | SH | $16.88M 3.29% | 663.61K | 0.00 | 0.00 |
SILENCE THERAPEUTICS PLCSOLE | ADS | 2.10M | SH | $13.05M 2.54% | 2.10M | 0.00 | 0.00 |
IMMUNOVANT, INCSOLE | COMM | 654.85K | SH | $10.16M 1.98% | 654.85K | 0.00 | 0.00 |
ENTRADA THERAPEUTICS INCSOLE | COMM | 584.96K | SH | $8.48M 1.65% | 584.96K | 0.00 | 0.00 |
STRUCTURE THERAPEUTICS INCSOLE | SPONSORED ADS | 350K | SH | $8.33M 1.62% | 350K | 0.00 | 0.00 |
MERUS BVSOLE | COMM | 300K | SH | $5.52M 1.08% | 300K | 0.00 | 0.00 |
ACLARIS THERAPEUTICS INCSOLE | COMM | 529.84K | SH | $4.29M 0.84% | 529.84K | 0.00 | 0.00 |
CABALETTA BIO, INCSOLE | COMM | 486.80K | SH | $4.03M 0.78% | 486.80K | 0.00 | 0.00 |
C4 THERAPEUTICS, INC.SOLE | COMM | 1.25M | SH | $3.92M 0.77% | 1.25M | 0.00 | 0.00 |
ALPINE IMMUNE SCIENCES INCSOLE | COMM | 253.07K | SH | $1.95M 0.38% | 253.07K | 0.00 | 0.00 |